2-127068982-C-T

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PP3_ModeratePP5

The NM_139343.3(BIN1):​c.461G>A​(p.Arg154Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,840 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R154W) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 34)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

BIN1
NM_139343.3 missense

Scores

7
11
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 7.85

Publications

17 publications found
Variant links:
Genes affected
BIN1 (HGNC:1052): (bridging integrator 1) This gene encodes several isoforms of a nucleocytoplasmic adaptor protein, one of which was initially identified as a MYC-interacting protein with features of a tumor suppressor. Isoforms that are expressed in the central nervous system may be involved in synaptic vesicle endocytosis and may interact with dynamin, synaptojanin, endophilin, and clathrin. Isoforms that are expressed in muscle and ubiquitously expressed isoforms localize to the cytoplasm and nucleus and activate a caspase-independent apoptotic process. Studies in mouse suggest that this gene plays an important role in cardiac muscle development. Alternate splicing of the gene results in several transcript variants encoding different isoforms. Aberrant splice variants expressed in tumor cell lines have also been described. [provided by RefSeq, Mar 2016]
BIN1 Gene-Disease associations (from GenCC):
  • myopathy, centronuclear, 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • centronuclear myopathy
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive centronuclear myopathy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PM1
In a domain BAR (size 247) in uniprot entity BIN1_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_139343.3
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.867
PP5
Variant 2-127068982-C-T is Pathogenic according to our data. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300. Variant chr2-127068982-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 8300.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BIN1NM_139343.3 linkc.461G>A p.Arg154Gln missense_variant Exon 6 of 19 ENST00000316724.10 NP_647593.1 O00499-1A0A024RAF1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BIN1ENST00000316724.10 linkc.461G>A p.Arg154Gln missense_variant Exon 6 of 19 1 NM_139343.3 ENSP00000316779.5 O00499-1

Frequencies

GnomAD3 genomes
Cov.:
34
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461840
Hom.:
0
Cov.:
35
AF XY:
0.00000688
AC XY:
5
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53398
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00000360
AC:
4
AN:
1112000
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
34
Alfa
AF:
0.0000363
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Myopathy, centronuclear, 2 Pathogenic:2Uncertain:1
Jan 08, 2019
SIB Swiss Institute of Bioinformatics
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:curation

This variant is interpreted as a Likely pathogenic for Myopathy, centronuclear, 2 autosomal recessive. The following ACMG Tag(s) were applied: PM2 : Absent from controls (or at extremely low frequency if recessive) in Exome Sequencing Project, 1000 Genomes Project, or Exome Aggregation Consortium. PS3 : Well-established functional studies show a deleterious effect (PMID:24755653). PP3 : Multiple lines of computational evidence support a deleterious effect on the gene or gene product. PM1 : Located in a mutational hot spot and/or critical and well-established functional domain (e.g., active site of an enzyme) without benign variation. -

Mar 26, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 154 of the BIN1 protein (p.Arg154Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with centronuclear myopathy (PMID: 20142620). ClinVar contains an entry for this variant (Variation ID: 8300). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BIN1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BIN1 function (PMID: 24755653, 25262827). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Feb 09, 2010
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.90
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Uncertain
0.12
CADD
Pathogenic
31
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.71
.;.;.;.;.;.;.;.;.;D;.
Eigen
Pathogenic
0.72
Eigen_PC
Uncertain
0.64
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Pathogenic
1.0
D;D;D;D;D;D;D;D;D;D;D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.87
D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.14
D
MutationAssessor
Uncertain
2.8
M;M;M;M;M;M;M;M;M;M;M
PhyloP100
7.8
PrimateAI
Uncertain
0.78
T
PROVEAN
Uncertain
-3.9
D;D;D;D;D;D;D;D;D;D;D
REVEL
Pathogenic
0.69
Sift
Uncertain
0.0010
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.0030
D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
D;D;D;D;D;D;D;D;D;P;D
Vest4
0.92
MVP
0.89
MPC
2.3
ClinPred
1.0
D
GERP RS
3.9
Varity_R
0.92
gMVP
0.78
Mutation Taster
=0/100
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs267606681; hg19: chr2-127826558; API